Gut & MicrobiomeYour Gut Bacteria Control Immune Cells That Drive Obesity and Heart Disease
Researchers from the Weizmann Institute and the German Cancer Research Center have published a comprehensive review showing how bacteria in your gut communicate with immune cells to influence metabolic health. Microbial byproducts — including short-chain fatty acids, bile acids, and indoles — alter immune cell behavior through mechanisms like epigenetic changes and energy-sensing pathways. These immune shifts can either protect against or promote conditions like obesity, type 2 diabetes, fatty liver disease, and cardiovascular disease. The review also highlights emerging therapies — from personalized nutrition and precision probiotics to postbiotics and microbial transplants — designed to target these immune-microbiome pathways and treat cardiometabolic disease.
